1.48000 USD
0.07
4.52%
Last update Dec 15, 3:58 PM EST
Pre-market
Day range
1.42500
1.55000
Previous close
1.55000
Open
1.55000
Access this stock data via API
Subscribe
Rein Therapeutics Inc.
1.48
0.07
4.52%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 1.7M 4.3M 3.1M 3.3M
Selling general and admin 3.8M 2.6M 2.6M 2.5M
Other operating expenses
Operating income -5.5M -6.9M -5.6M -5.8M
Non operating interest income
Income
Expense
Other income expense -89K 49K 108K -37.0M
Pretax income -5.6M -6.8M -5.5M -42.4M
Tax provision
Net income -5.6M -6.8M -5.5M -40.9M
Basic EPS -0.2 -0.3 -0.3
Diluted EPS -0.2 -0.3 -0.3
Basic average shares 26.4M 24.2M 21.9M
Diluted average shares 26.4M 24.2M 21.9M
EBITDA -5.5M -6.9M -5.6M 30.9M
Net income from continuing op. -5.6M -6.8M -5.5M -41.0M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Pre-market

Exchange is currently open for pre-market.
Main market opens in 2 hours 48 minutes

06:41
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).